165 related articles for article (PubMed ID: 6088002)
1. Radiosensitizers and protectors.
Nori D; Kim JH; Hilaris BS; Chu F
Cancer Invest; 1984; 2(4):321-30. PubMed ID: 6088002
[No Abstract] [Full Text] [Related]
2. Sensitizers and protectors in clinical oncology.
Phillips TL
Semin Oncol; 1981 Mar; 8(1):65-82. PubMed ID: 6264627
[No Abstract] [Full Text] [Related]
3. Sensitizers and protectors in radiotherapy.
Brown JM
Cancer; 1985 May; 55(9 Suppl):2222-8. PubMed ID: 2983876
[TBL] [Abstract][Full Text] [Related]
4. [Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue].
Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G
Radiobiol Radiother (Berl); 1983; 24(5):597-614. PubMed ID: 6316407
[No Abstract] [Full Text] [Related]
5. The potential for radiation sensitizers and radiation protectors combined with radiation therapy in gynecologic cancer.
Brady LW; Phillips TL; Wasserman TH
Cancer; 1981 Jul; 48(2 Suppl):650-7. PubMed ID: 6268288
[TBL] [Abstract][Full Text] [Related]
6. Combined radiosensitization and radioprotection for oral cavity tumors: study with an oral cavity tumor model.
Grigsby P; Maruyama Y
Int J Radiat Oncol Biol Phys; 1982; 8(3-4):557-9. PubMed ID: 6286553
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic cell radiosensitizers.
Fowler JF
Strahlentherapie Sonderb; 1978; 75():12-9. PubMed ID: 400196
[No Abstract] [Full Text] [Related]
8. Chemical radiation sensitizers and protectors: recent developments.
Kim JH; Chu FC
Clin Bull; 1981; 11(1):5-11. PubMed ID: 6268335
[No Abstract] [Full Text] [Related]
9. Proceedings of the Fourth International Cytoprotection Investigators' Congress. May 2004. Philadelphia, Pennsylvania, USA.
Semin Oncol; 2004 Dec; 31(6 Suppl 18):1-73. PubMed ID: 15801121
[No Abstract] [Full Text] [Related]
10. Sensitizers in radiotherapy.
Dische S
Br J Hosp Med; 1982 May; 27(5):502, 507-10. PubMed ID: 7093576
[No Abstract] [Full Text] [Related]
11. The application in radiation therapy of substances which modify cellular radiation response.
Chapman JD; Urtasun RC
Cancer; 1977 Jul; 40(1 Suppl):484-8. PubMed ID: 195712
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic study of paclitaxel administered with or without the cytoprotective agent amifostine, and given as a single agent or in combination with epirubicin and cisplatin in patients with advanced solid tumors.
Van den Brande J; Nannan Panday VR; Hoekman K; Rosing H; Huijskes RV; Verheijen RH; Beijnen JH; Vermorken JB
Am J Clin Oncol; 2001 Aug; 24(4):401-3. PubMed ID: 11474273
[TBL] [Abstract][Full Text] [Related]
13. Radiation-induced toxicities: the role of radioprotectants.
Curran WJ
Semin Radiat Oncol; 1998 Oct; 8(4 Suppl 1):2-4. PubMed ID: 9794993
[TBL] [Abstract][Full Text] [Related]
14. Role of hypoxic sensitizers in radiotherapy.
Singh DR; Krishnan D
Indian J Cancer; 1981 Mar; 18(1):63-8. PubMed ID: 7262909
[No Abstract] [Full Text] [Related]
15. Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
Kanclerz A; Chapman JD
Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):309-16. PubMed ID: 2828290
[TBL] [Abstract][Full Text] [Related]
16. Chemical modification of radiation and chemotherapy.
Brown JM; Hall EJ; Hirst DG; Kinsella TJ; Kligerman MM; Mitchell JB; Travis EJ; Valeriote F
Am J Clin Oncol; 1988 Jun; 11(3):288-303. PubMed ID: 3289362
[No Abstract] [Full Text] [Related]
17. Aggressive multimodality therapy for patients with locally advanced esophageal cancer: is there a role for amifostine?
Jatoi A
Semin Oncol; 2003 Dec; 30(6 Suppl 18):72-5. PubMed ID: 14727244
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic sensitizers--implications for radiation therapy.
Chapman JD
N Engl J Med; 1979 Dec; 301(26):1429-32. PubMed ID: 229413
[No Abstract] [Full Text] [Related]
19. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
[No Abstract] [Full Text] [Related]
20. [Amifostine as a supporting treatment during cancer therapy].
Jantunen E; Puistola U
Duodecim; 1999; 115(11):1223-7. PubMed ID: 11877841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
